Alzheimer's clinical trials in need of more Black participants

Studies show Black Americans are impacted twice as much as white Americans when it comes to Alzheimer's disease. The number of Black Americans involved in research and clinical trials is low. Wake Forest School of Medicine is on a mission to diversify research and close the gap.

Dr. Goldie Byrd is the director of the Maya Angelou Center for Health Equity at Wake Forest School of Medicine. She has spent much of her career researching the genetics of Alzheimer's in African Americans with a particular emphasis on diversifying research studies in clinical trials.

Read more here:


Follow us:
Facebook |
Twitter |
Instagram |

Download the WFMY News 2 app:
►Text the word APP to 336-379-5775
►For iPhone |
►For Android |
Be the first to comment